Dr. Sanjay GuptaVerified account

@drsanjaygupta

Associate Professor of Neurosurgery. Emory University Hospital; CNN Chief Medical Correspondent

Home
Joined December 2008

Tweets

You blocked @drsanjaygupta

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @drsanjaygupta

  1. Pinned Tweet

    Please don’t get complacent this weekend. I know it will be hard, as this is really starting to settle in for many. Stay home. Slow down. Tidy up. Call an old friend, as they are hopefully home as well. Please behave as if you have the virus. So, be kind.

    Undo
  2. Retweeted

    Life needs to change for a while. Keep a reasonable distance from others and stay at home as much as possible. Slow down. Be mindful of all the surfaces you touch and clean them after. Yes, wash your hands — a lot. And, don’t touch your face. You shouldn’t panic — just prepare.

    Undo
  3. May 1

    Very swift human trials happening to test possible coronavirus vaccine candidates. May have data to share in next few months. Animal trials important — but as someone once said “mice lie and monkeys exaggerate.”

    Undo
  4. May 1

    She gave the best explanation I have heard as to why our dreams have been so strange lately.

    Undo
  5. Very interesting article and interactive by ⁦⁩ Click through the various scenarios

    Undo
  6. That means so much from you Richard, our moral compass and North Star. Miss you my friend

    Undo
  7. Thank you for all your hard work You have helped so many people.

    Undo
  8. Now, meet one brave man: 31-year-old Emory medical student and Ph.D. candidate Sean Doyle. Sean is a volunteer in one of the Covid-19 vaccine trials in Atlanta, putting his life at risk for the benefit of the greater good. (20/20)

    Show this thread
    Undo
  9. One RNA vaccine, called mRNA-1273, is currently being investigated by the U.S. biotech firm Moderna. Dr. Anthony Fauci recently told CNN that a clinical trial could start by the end of April. (19/20)

    Show this thread
    Undo
  10. According to the , 30 RNA vaccines for COVID are currently in the trial or pretrial phases. That’s about 1/3rd of all COVID vaccines in development (18/20)

    Show this thread
    Undo
  11. So far, research into RNA vaccines appears promising. In 2016, an RNA vaccine produced a robust immune response to Ebola, H1N1 influenza, and toxoplasma. (17/20)

    Show this thread
    Undo
  12. According to Dr. Amesh Adalja: “There is no precedent yet for [RNA vaccines] being approved for use and, and we don't know everything about them in terms of how they're going to behave in large numbers of people and what the side effect profile they might be.” (16/20)

    Show this thread
    Undo
  13. Unlike a normal vaccine, RNA vaccines work by introducing an mRNA messenger molecule that codes for a protein expressed on the surface of the virus or bacteria. (15/20)

    Show this thread
    Undo
  14. Hope for a speedy yet safe Covid-19 vaccine now lies with a new technology: RNA vaccines. These vaccines are thought to be faster and easier to develop than other types. (14/20)

    Show this thread
    Undo
  15. Right now, there is a push to expedite a Covid-19 vaccine. But we need to be cautious. In 1976, President Ford tried to expedite a swine flu vaccine and ~450 people developed Guillain-Barré syndrome, a rare neurological disorder. (13/20)

    Show this thread
    Undo
  16. Right now, researchers hope to develop a Covid-19 vaccine in the next 1-2 years. But there isn’t a precedent for such a short approval process. The fastest approval to date -- for the mumps vaccine -- took four years. (12/20)

    Show this thread
    Undo
  17. Vaccine development is normally a very long process and includes at least three phases. The first and second evaluate for safety and efficacy using a small number of volunteers. The third looks at side effects on a larger scale involving tens of thousands of people. (11/20)

    Show this thread
    Undo
  18. Others, like the pertussis vaccine, only include proteins present on the surface of the pathogen. These types of vaccines are not always as effective in the long-term and boosters are often necessary. (10/20)

    Show this thread
    Undo
  19. Some -- like the MMR we receive as children -- include weakened forms of a virus or bacteria that do not cause disease but prime the immune system to attack it in the future. (9/20)

    Show this thread
    Undo
  20. Today, there are a lot of different kinds of vaccines, and not all vaccines are created equal. (8/20)

    Show this thread
    Undo
  21. One of the most successful vaccine campaigns in the US targeted the measles virus. The measles vaccine was first available in the United States in 1963. Over the next 12 years, nearly 19 million doses would be administered across the United States. (7/20)

    Show this thread
    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·